UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic involvement in adult‐onset leukoencephalopathy with intracranial calcifications and cysts (Labrune syndrome) with a novel mutation of the SNORD118 gene

European journal of neurology, 2020-11, Vol.27 (11), p.2329-2332

2020

Volltextzugriff (PDF)

Connectivity of Ephemeral and Intermittent Streams in a Subtropical Atlantic Forest Headwater Catchment

Water (Basel), 2020-06, Vol.12 (6), p.1526

2020

Volltextzugriff (PDF)

Successful second autologous engraftment after long duration storage of hematopoietic stem cells

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1480-1481

2013

Volltextzugriff (PDF)

Clinical presentation, comorbidities and treatment of GAD antibodies associated Stiff Person Syndrome

Parkinsonism & related disorders, 2023-08, Vol.113

2023

Volltextzugriff (PDF)

The US dollar as world reserve currency: The United States limits of monetary policy autonomy

Meridiano 47, 2013-11, Vol.14 (140), p.3-10

Arienti, Patricia F F

2013

Volltextzugriff (PDF)

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens

The Journal of immunology (1950), 2004-05, Vol.172 (9), p.5363-5370

2004

Volltextzugriff (PDF)

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

International journal of cancer, 1999-01, Vol.80 (2), p.219-230

1999

Volltextzugriff (PDF)

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Cancer Immunology, Immunotherapy, 2006-08, Vol.55 (8), p.958-968

2006

Volltextzugriff (PDF)

Soluble human LAG-3 molecule amplifies the In vitro generation of type 1 tumor-specific immunity

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (8), p.4450-4460

2006

Volltextzugriff (PDF)

Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration

European journal of cancer (1990), 1993, Vol.29 (9), p.1266-1269

1993

Volltextzugriff (PDF)

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

International journal of cancer, 1995-12, Vol.63 (6), p.883-885

1995

Volltextzugriff (PDF)

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (20), p.6948-6955

2003

Volltextzugriff (PDF)

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

International journal of cancer, 1995-12, Vol.63 (6), p.883-885

1995

Volltextzugriff (PDF)

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma

The Journal of clinical investigation, 1998-06, Vol.101 (12), p.2720-2729

1998

Volltextzugriff (PDF)

Accidents in Patients with Epilepsy: Types, Circumstances, and Complications: A European Cohort Study

Epilepsia (Copenhagen), 2004-06, Vol.45 (6), p.667-672

2004

Volltextzugriff (PDF)

Morbidity and Accidents in Patients with Epilepsy: Results of a European Cohort Study

Epilepsia (Copenhagen), 2002-09, Vol.43 (9), p.1076-1083

2002

Volltextzugriff (PDF)

Expression of MAGE genes in primary and metastatic cutaneous melanoma

International journal of cancer, 1995-11, Vol.63 (3), p.375-380

1995

Volltextzugriff (PDF)

Health-related quality of life in epilepsy: Findings obtained with a new Italian instrument

Epilepsy & behavior, 2008-07, Vol.13 (1), p.119-126

2008

Volltextzugriff (PDF)

Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study

Human gene therapy, 1994-08, Vol.5 (8), p.1059-1064

1994

Volltextzugriff (PDF)

Active immunization of metastatic melanoma patients with IL-2 or IL-4 gene transfected, allogeneic melanoma cells

Advances in experimental medicine and biology, 1998, Vol.451, p.543

1998

Volltextzugriff (PDF)

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

JNCI : Journal of the National Cancer Institute, 1995-10, Vol.87 (19), p.1463-1469

1995

Volltextzugriff (PDF)

Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

Cancer Immunology, Immunotherapy, 2002-03, Vol.51 (1), p.9-14

2002

Volltextzugriff (PDF)

Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy

The Journal of immunology (1950), 1996-05, Vol.156 (10), p.3882-3891

1996

Volltextzugriff (PDF)

Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells

Human gene therapy, 1999-12, Vol.10 (18), p.2907-2916

1999

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Systemic involvement in adult‐onset leukoencephalopathy with intracranial calcifications and cysts (Labrune syndrome) with a novel mutation of the SNORD118 gene

Connectivity of Ephemeral and Intermittent Streams in a Subtropical Atlantic Forest Headwater Catchment

Successful second autologous engraftment after long duration storage of hematopoietic stem cells

Clinical presentation, comorbidities and treatment of GAD antibodies associated Stiff Person Syndrome

The US dollar as world reserve currency: The United States limits of monetary policy autonomy

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Soluble human LAG-3 molecule amplifies the In vitro generation of type 1 tumor-specific immunity

Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma

Accidents in Patients with Epilepsy: Types, Circumstances, and Complications: A European Cohort Study

Morbidity and Accidents in Patients with Epilepsy: Results of a European Cohort Study

Expression of MAGE genes in primary and metastatic cutaneous melanoma

Health-related quality of life in epilepsy: Findings obtained with a new Italian instrument

Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study

Active immunization of metastatic melanoma patients with IL-2 or IL-4 gene transfected, allogeneic melanoma cells

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy

Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells

Suchergebnisse filtern